Description

1. Product Overview: Semaxen 3® is a GLP-1 receptor agonist formulation containing Semaglutide, used for improving glycemic control in patients with type 2 diabetes mellitus and supporting weight management under medical supervision.
2. Composition: Semaglutide INN 3 mg | Dosage Form: Injection (as available)
3. Pharmacological Class: GLP-1 Receptor Agonist (Antidiabetic Agent)
4. Mechanism of Action: Semaglutide mimics the action of glucagon-like peptide-1 (GLP-1), enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite, thereby improving blood glucose control.
5. Indications: Type 2 diabetes mellitus | Adjunct to diet and exercise for glycemic control | Weight management support in eligible patients
6. Dosage & Administration: As directed by physician only | Subcutaneous administration | Dose and schedule must be individualized by a healthcare professional
7. Clinical Benefits: Improves blood glucose control | Supports weight reduction | Reduces appetite | Lowers risk of diabetes-related complications
8. Contraindications: Hypersensitivity to Semaglutide or any component of the formulation | Personal or family history of medullary thyroid carcinoma | Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
9. Precautions: Risk of pancreatitis | Monitor renal function in at-risk patients | Not recommended for type 1 diabetes | Use only under strict medical supervision
10. Drug Interactions: May affect absorption of oral medications due to delayed gastric emptying | Caution with insulin or sulfonylureas (risk of hypoglycemia)
11. Special Populations: Not recommended during pregnancy or breastfeeding unless clearly advised by physician | Use in elderly under medical supervision
12. Adverse Effects: Nausea | Vomiting | Diarrhea | Abdominal discomfort | Reduced appetite | Possible risk of pancreatitis (rare)
13. Storage Conditions: Store in refrigerator (2°C to 8°C) | Do not freeze | Protect from light | Keep out of reach of children
14. Packaging: Prefilled injection pen / vial (as available)
15. Manufacturer: Everest Pharmaceutical Ltd.